MedTrace Logo

Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

NCT02678585 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2018-06-26

No results posted yet for this study

Summary

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

Conditions

  • Postoperative Pain

Interventions

DRUG

Nalbuphine

53 patients received intravenous regional lidocaine plus nalbuphine

DRUG

Lidocaine

53 patients received intravenous regional lidocaine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02678585 on ClinicalTrials.gov